SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-001800
Filing Date
2024-03-04
Accepted
2024-03-04 17:36:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4844
  Complete submission text file 0001950047-24-001800.txt   6440
Mailing Address MORRIS CORP. CENTER I; BLDG. B; 4TH FLR. 300 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address
COLES N ANTHONY (Reporting) CIK: 0001197018 (see all company filings)

Type: 144

Mailing Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141
Business Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Subject) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39311 | Film No.: 24716508
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)